Manufacturing problems cited in FDA rejection of ITM’s radiopharma drug
Summary:
ITM-11 showed promising Phase 3 efficacy, but FDA manufacturing concerns have delayed approval, highlighting production challenges in the fast-growing radiopharmaceutical field.
Novo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hub
Summary:
Novo Nordisk and AWS are joining forces to embed AI across drug discovery, combining cloud infrastructure and biological expertise to accelerate new medicines.
Inizio Engage expands medical information digs with Connected Insights platform
Summary:
Inizio Engage launches an AI-enabled medical information platform connecting global expertise, regional insights, and scientific interactions to strengthen decision-making across Medical Affairs.
aTyr lays off 60% of workforce to fund 2nd attempt at phase 3 success for lung disease drug
Summary:
aTyr’s heavy cut on its workforce stated preserve cash for a second phase 3 attempt testing efzofitimod in pulmonary sarcoidosis.
What’s missing from the White House plan for the future of US science
Summary:
The White House’s science blueprint prioritizes strategic technologies while overlooking global collaboration, public health, climate science, and the social sciences needed for a true scientific renaissance.
